Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Takeya TsutsumiTatsuo Miyamura

Abstract

Hepatic steatosis and hepatocellular carcinoma (HCC) are common and serious features of hepatitis C virus (HCV) infection, and the core protein has been shown to play distinct roles in the pathogenesis. Here we report the direct interaction of HCV core protein with retinoid X receptor alpha (RXRalpha), a transcriptional regulator that controls many aspects of cell proliferation, differentiation, and lipid metabolism. The core protein binds to the DNA-binding domain of RXRalpha, leading to increase the DNA binding of RXRalpha to its responsive element. In addition, RXRalpha is activated in cells expressing the core protein as well as in the livers of the core-transgenic mice that would develop hepatic steatosis and HCC later in their lives. Using promoter genes of cellular retinol binding protein II (CRBPII) and acyl-CoA oxidase as reporters, we also show that the expression of the core protein enhances the transcriptional activity regulated by the RXRalpha homodimer as well as by the heterodimer with peroxisome proliferator activated receptor alpha. Furthermore, expression of the CRBPII gene is also up-regulated in the livers of HCV core-transgenic mice. In conclusion, these results suggest that modulation of RXRalpha-controlle...Continue Reading

References

Apr 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N BachF Schaffner
May 25, 1991·Nucleic Acids Research·Y ImaiM Terada
Jun 1, 1991·Journal of Virology·S HaradaT Miyamura
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E LiJ I Gordon
Dec 15, 1994·Biochemical and Biophysical Research Communications·S C ChangM F Chang
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
Jul 1, 1997·The Journal of General Virology·K MoriyaK Koike
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H AizakiT Miyamura
Jun 17, 1998·Journal of Virology·K YasuiM Kohara
Jul 4, 1998·The Journal of Biological Chemistry·T Y HsiehM M Lai
Nov 13, 1998·The Journal of Biological Chemistry·S Y NaJ W Lee
Jun 24, 1999·Journal of the National Cancer Institute·E PicardJ M Vignaud
Jun 26, 1999·The Journal of Biological Chemistry·S Adam-StitahC Rochette-Egly
Oct 12, 1999·Intervirology·R SuzukiT Miyamura
Mar 4, 2000·The EMBO Journal·F RastinejadS Khorasanizadeh

❮ Previous
Next ❯

Citations

Jul 29, 2005·Digestive Diseases and Sciences·Atsushi YamaguchiKazuaki Chayama
Jun 1, 2008·Hepatology International·Ching-Sheng HsuJia-Horng Kao
Mar 17, 2010·Oncogene·W-L Tsai, R T Chung
May 2, 2002·Journal of Gastroenterology and Hepatology·Kazuhiko KoikeSatoshi Kimura
Oct 11, 2011·The Journal of Biological Chemistry·Charles HarrisMelanie Ott
Nov 18, 2011·The Journal of Biological Chemistry·Eva Herker, Melanie Ott
Apr 11, 2008·Journal of Gastroenterology and Hepatology·Kazuhiko KoikeKyoji Moriya
Jul 30, 2009·Journal of Gastroenterology and Hepatology·Mario CongiuPaul V Desmond
Oct 1, 2009·Journal of Gastroenterology and Hepatology·Takeharu AsanoShin Ohnishi
Jan 12, 2008·The Journal of Clinical Investigation·Naoki TanakaToshifumi Aoyama
Mar 2, 2010·Biological & Pharmaceutical Bulletin·Masayoshi Fukasawa
Mar 25, 2008·Uirusu·Kohji Moriishi, Yoshiharu Matsuura
Dec 7, 2013·World Journal of Gastroenterology : WJG·Mohammad IrshadKhushboo Irshad
Feb 21, 2013·Hepatitis Monthly·Masoomeh SofianAmitis Ramezani
Apr 15, 2006·International Journal of Medical Sciences·Eugene J Yoon, Ke-Qin Hu
Apr 8, 2014·World Journal of Gastroenterology : WJG·Nora A FierroArturo Panduro
Oct 1, 2011·Future Microbiology·Matthew S Miller, Joe S Mymryk
Jan 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kohji MoriishiYoshiharu Matsuura
Feb 20, 2009·Journal of Gastroenterology·Kazuhiko Koike
Sep 13, 2011·Expert Review of Anti-infective Therapy·Maria Ripoli, Valerio Pazienza
May 26, 2012·Antiviral Research·Matthieu BlanchetPatrick Labonté
Dec 14, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Mario ArcielloClara Balsano
Oct 22, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Jian-Min WuMary A Maluccio
May 31, 2011·Pharmacology & Therapeutics·Zoe RaglowYu-Jui Yvonne Wan
Feb 15, 2011·Clinics and Research in Hepatology and Gastroenterology·Patrice AndréVincent Lotteau
Feb 18, 2011·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Salvatore PettaAntonio Craxì
Feb 7, 2009·Diabetes & Metabolism·M Alaei, F Negro
Jul 16, 2008·Clinics in Liver Disease·Wojciech Blonski, K Rajender Reddy
Jun 13, 2008·Antiviral Research·Claire TrottierBrian J Ward
Feb 9, 2008·Cellular Signalling·Matthew D UrbanowskiTom C Hobman
Jul 28, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Tzy-Yen ChenHui-Ling Chiou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.